PRT2527
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PRT2527, covering 2026-01-26 to 2026-01-26. Get the full timeline:
Most recent: Clinical Trial Update: A Study of PRT2527 as Monotherapy and in Combination With Zanubrutinib or Venetoclax in Participants With R/R Hematologic Malignancies [Phase 1]